Page 137 - 2019_04-Haematologica-web

Thromboembolism and thromboprophylaxis in pediatric ALL
lymphoblastic leukemia. Pediatr Blood
Cancer. 2008;50(2):298-303.
24 Goossens GA. Flushing and locking of
venous catheters: available evidence and evi- dence deficit. Nurs Res Pract. 2015;2015: 985686.
25 Hentschel R, Sutor AH. Catheter-related thrombosis and its prevention in infancy. Hamostaseologie. 2002;22(4):167-173.
26 Lersch C. Prevention of catheter-induced thromboses by low molecular weight heparins. Hamostaseologie. 2002;22(4):161- 166.
27 Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled tri- als. Chest. 1998;113(1):165-171.
28 Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adoles- cents with B-cell precursor acute lym- phoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010;115(16):3206-3214.
29 Möricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood. 2016;127(17):2101-2112.
30 Schrappe M, Valsecchi MG, Bartram CR, et al. Late MRD response determines relapse risk overall and in subsets of childhood T- cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011;118(8):2077-2084.
31 Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular- weight heparin in pediatric patients with thrombotic disease: a dose finding study. J
Pediatr. 1996;128(3):313-318. analysis of failure time data. 1980;1st163- 32 Punzalan RC, Hillery CA, Montgomery RR, 188.
Scott CA, Gill JC. Low-molecular-weight 42 Gray RJ. A class of K-sample tests for com- heparin in thrombotic disease in children paring the cumulative incidence of a com- and adolescents. J Pediatr Hematol Oncol. peting risk. Ann Stat. 1988;16(3):1141-1154. 2000;22(2):137-142. 43 Santoro N, Colombini A, Silvestri D, et al.
33 Dix D, Andrew M, Marzinotto V, et al. The Screening for coagulopathy and identifica- use of low molecular weight heparin in tion of children with acute lymphoblastic pediatric patients: a prospective cohort leukemia at a higher risk of symptomatic study. J Pediatr. 2000;136(4):439-445. venous thrombosis: an AIEOP experience. J
34 Schneppenheim R, Greiner J. Thrombosis in Pediatr Hematol Oncol. 2013;35(5):348- infants and children. Hematology Am Soc 355.
Hematol Educ Program. 2006;86-96. 44 Giordano P, Santoro N, Del Vecchio GC,
35 Schulman S, Kearon C. Definition of major Rizzari C, Masera G, de Mattia D. T- bleeding in clinical investigations of antihe- immunophenotype is associated with an mostatic medicinal products in non-surgical increased prevalence of thrombosis in chil- patients. J Thromb Haemost. 2005;3(4):692- dren with acute lymphoblastic leukemia. A 694. retrospective study. Haematologica. 2003;88
36 Levine MN, Raskob G, Landefeld S, Kearon (9):1079-1080.
C. Hemorrhagic complications of anticoagu- 45 Hernandez-Espinosa D, Minano A, lant treatment. Chest. 2001;119(1 Ordonez A, et al. Dexamethasone induces a Suppl):108S-121S. heat-stress response that ameliorates the
37 Committee for proprietary medicinal prod- conformational consequences on antithrom- ucts (CPMP). Notes for guidance on clinical bin of L-asparaginase treatment. J Thromb investigation of medicinal products for treat- Haemost. 2009;7(7):1128-1133.
ment of venous thromboembolic disease. 46 Bushman JE, Palmieri D, Whinna HC, http://www ema europe eu 2016; CPMP/ Church FC. Insight into the mechanism of EWP/563/98 asparaginase-induced depletion of
38 Kaplan ES, Meier P. Nonparametric estima- antithrombin III in treatment of childhood tion from incomplete observations. J Am acute lymphoblastic leukemia. Leuk Res. Stat Assoc. 1958;53(282):457-481. 2000;24(7):559-565.
39 Mantel N. Evaluation of survival data and 47 Payne JH, Vora AJ. Thrombosis and acute two new rank order statistics arising in its lymphoblastic leukaemia. Br J Haematol. consideration. Cancer Chemother Rep. 2007;138(4):430-445.
1966;50(3):163-170. 48 Appel IM, Hop WC, van Kessel-Bakvis C,
40 Cox DR. Regression models and life-tables. J Stigter R, Pieters R. L-asparaginase and the R Stat Soc Series B Stat Methodol. effect of age on coagulation and fibrinolysis 1972;42(2):187-220. in childhood acute lymphoblastic leukemia.
41 Kalbfleisch JD, Prentice RL. The statistical Thromb Haemost. 2008;100(2):330-337.
haematologica | 2019; 104(4)
765